Primary |
Product Used For Unknown Indication |
24.1% |
Drug Use For Unknown Indication |
14.6% |
Hypertension |
8.0% |
Bile Duct Cancer |
5.8% |
Gastrooesophageal Reflux Disease |
5.8% |
Colon Cancer |
4.4% |
Gout |
4.4% |
Nausea |
4.4% |
Dyspepsia |
3.6% |
Cerebral Infarction |
2.9% |
Constipation Prophylaxis |
2.9% |
Phlebitis |
2.9% |
Urticaria |
2.9% |
Dementia Alzheimer's Type |
2.2% |
Gastrointestinal Disorder |
2.2% |
Skin Papilloma |
2.2% |
Type 2 Diabetes Mellitus |
2.2% |
Cystitis Interstitial |
1.5% |
Depression |
1.5% |
Gastritis |
1.5% |
|
Death |
11.1% |
Drug Ineffective |
7.4% |
Vomiting |
7.4% |
Dyskinesia |
5.6% |
International Normalised Ratio Increased |
5.6% |
Jaundice |
5.6% |
Swelling Face |
5.6% |
Urticaria |
5.6% |
Vision Blurred |
5.6% |
Diarrhoea |
3.7% |
Drug Interaction |
3.7% |
Drug Screen Positive |
3.7% |
Hypotonia |
3.7% |
Myalgia |
3.7% |
Renal Failure Acute |
3.7% |
Renal Impairment |
3.7% |
Stomach Discomfort |
3.7% |
Tremor |
3.7% |
Tubulointerstitial Nephritis |
3.7% |
Vasculitis |
3.7% |
|
Secondary |
Product Used For Unknown Indication |
52.0% |
Drug Use For Unknown Indication |
17.6% |
Gastrooesophageal Reflux Disease |
3.6% |
Accidental Drug Intake By Child |
2.8% |
Dementia Alzheimer's Type |
2.6% |
Pain |
2.5% |
Depression |
2.1% |
Hypertension |
2.1% |
Chemotherapy |
1.9% |
Urticaria |
1.7% |
Gastroduodenal Ulcer |
1.5% |
Gastritis |
1.3% |
Anaesthesia |
1.1% |
Duodenitis |
1.1% |
Rheumatoid Arthritis |
1.1% |
Type 2 Diabetes Mellitus |
1.1% |
Accidental Exposure To Product By Child |
0.9% |
Embolism Venous |
0.9% |
Lung Neoplasm Malignant |
0.9% |
Premedication |
0.9% |
|
Toxicity To Various Agents |
12.9% |
Death |
11.9% |
Overdose |
7.9% |
Renal Failure Acute |
7.9% |
Completed Suicide |
6.9% |
Drug Hypersensitivity |
5.0% |
Medication Error |
5.0% |
Drug Interaction |
4.0% |
Poisoning |
4.0% |
Rash |
4.0% |
Vomiting |
4.0% |
Diarrhoea |
3.0% |
Haemolytic Anaemia |
3.0% |
Pruritus |
3.0% |
Respiratory Arrest |
3.0% |
Sepsis |
3.0% |
Serotonin Syndrome |
3.0% |
Thrombocytopenia |
3.0% |
Tremor |
3.0% |
Urticaria |
3.0% |
|
Concomitant |
Product Used For Unknown Indication |
20.5% |
Drug Use For Unknown Indication |
17.3% |
Rheumatoid Arthritis |
9.1% |
Premedication |
7.0% |
Prophylaxis |
6.5% |
Breast Cancer |
6.2% |
Hypertension |
5.0% |
Pain |
4.5% |
Non-small Cell Lung Cancer |
3.6% |
Breast Cancer Metastatic |
2.7% |
Gastrooesophageal Reflux Disease |
2.7% |
Depression |
2.7% |
Diabetes Mellitus |
2.3% |
Metastases To Bone |
1.9% |
Ovarian Cancer |
1.6% |
Insomnia |
1.6% |
Anxiety |
1.3% |
Osteoporosis |
1.3% |
Asthma |
1.2% |
Nausea |
1.2% |
|
Vomiting |
18.9% |
Weight Decreased |
7.0% |
Rhabdomyolysis |
6.6% |
Nausea |
6.4% |
Vitreous Floaters |
5.3% |
Pneumonia |
5.1% |
Pyrexia |
5.1% |
Sepsis |
5.1% |
Weight Increased |
5.1% |
Septic Shock |
4.2% |
White Blood Cell Count Decreased |
4.2% |
Urinary Tract Infection |
3.7% |
Wound Treatment |
3.5% |
Myocardial Infarction |
3.3% |
Thrombocytopenia |
3.3% |
Renal Failure |
2.9% |
Death |
2.6% |
Neutropenia |
2.6% |
Neutropenic Sepsis |
2.6% |
Vision Blurred |
2.6% |
|
Interacting |
Product Used For Unknown Indication |
42.9% |
Fall |
11.4% |
Fracture |
11.4% |
Gastrooesophageal Reflux Disease |
11.4% |
Pain |
11.4% |
Gastroduodenal Ulcer |
5.7% |
Type 2 Diabetes Mellitus |
5.7% |
|
Intra-abdominal Haematoma |
14.3% |
Pancreatitis Acute |
14.3% |
Rash |
14.3% |
Renal Failure Acute |
14.3% |
Swelling |
14.3% |
White Blood Cell Count Increased |
14.3% |
Drug Interaction |
7.1% |
Serotonin Syndrome |
7.1% |
|